Evidence map›Paper›PMID 38910409›Full record

ArticleFaraday discussions2024

Harnessing conformational dynamics in enzyme catalysis to achieve nature-like catalytic efficiencies: the shortest path map tool for computational enzyme redesign.

Cristina Duran, Guillem Casadevall, Sílvia Osuna

Abstract read
In one paragraph

Article in Faraday discussions, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Deciphering opening mechanisms of 14-3-3 proteins.Protein science : a publication of the Protein Society · 2025
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Cristina DuranDepartament de Química, Institut de Química Computacional i Catàlisi, Universitat de Girona, c/Maria Aurèlia Capmany 69, 17003, Girona, Spain. silvia.osuna@udg.edu.ORCID 0000-0003-3094-8823
Guillem CasadevallDepartament de Química, Institut de Química Computacional i Catàlisi, Universitat de Girona, c/Maria Aurèlia Capmany 69, 17003, Girona, Spain. silvia.osuna@udg.edu.ORCID 0000-0003-4442-1600
Sílvia OsunaDepartament de Química, Institut de Química Computacional i Catàlisi, Universitat de Girona, c/Maria Aurèlia Capmany 69, 17003, Girona, Spain. silvia.osuna@udg.edu.ORCID 0000-0003-3657-6469

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzymes exhibit diverse conformations, as represented in the free energy landscape (FEL). Such conformational diversity provides enzymes with the ability to evolve towards novel functions. The challenge lies in identifying mutations that enhance specific conformational changes, especially if located in distal sites from the active site cavity. The shortest path map (SPM) method, which we developed to address this challenge, constructs a graph based on the distances and correlated motions of residues observed in nanosecond timescale molecular dynamics (MD) simulations. We recently introduced a template based AlphaFold2 (tAF2) approach coupled with 10 nanosecond MD simulations to quickly estimate the conformational landscape of enzymes and assess how the FEL is shifted after mutation. In this study, we evaluate the potential of SPM when coupled with tAF2-MD in estimating conformational heterogeneity and identifying key conformationally-relevant positions. The selected model system is the beta subunit of tryptophan synthase (TrpB). We compare how the SPM pathways differ when integrating tAF2 with different MD simulation lengths from as short as 10 ns until 50 ns and considering two distinct Amber forcefield and water models (ff14SB/TIP3P

Indexed as

BiocatalysisMolecular Dynamics SimulationProtein ConformationCatalytic DomainTryptophan SynthaseTryptophan Synthase

Identifiers

PMID38910409
PMCPMC11389851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.